Steven Yatomi Clarke – CEO and Managing Director – Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
Copyright 2023 – Finance News Network
12 Oct 2022 - VRX Silica Limited (ASX:VRX) Managing Director Bruce Maluish discusses the global demand for glass and the burgeoning silica sand sector in Australia.
17 Dec 2019 - Integrated Payment Technologies (ASX:IP1) CEO, Dean Martin discusses its payments solutions ClickSuper and PayVu, industry tailwinds, new features and platform integration.
09 Sep 2024 - ABx Group Limited (ASX:ABX) Managing Director and CEO Dr Mark Cooksey discusses the significance of the company's memorandum of understanding with Ucore Rare Metals.
16 March 2022 - WT Financial Group Limited (ASX:WTL) Founder and Managing Director Keith Cullen discusses the acquisition of Synchron and what this means for WT.
29 Sep 2023 - Vital Metals Limited (ASX:VML) Interim Non-Executive Chairman Richard Crookes discusses termination of the company's Saskatoon facility, the Tardiff rare earths asset, and next steps for the company.
04 Mar 2024 - Dean Tuck - Managing Director - Dreadnought Resources (ASX:DRE) is a highly active West Australian mineral explorer focused on finding the metals needed now and in the future.
06 Jan 2021 - Nyrada Limited (ASX:NYR) CEO James Bonnar discusses the cholesterol-lowering market, and recent results for the company's lead drug candidate, which achieved a 57% reduction in total cholesterol.
02 Oct 2024 - Lithium Universe Limited (ASX:LU7) CEO Alex Hanly discusses the company's prefeasibility study, operational costs and development timeline.